{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-001971","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.683956+00:00","generated_at":"2026-05-15T08:38:33.112912+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Texas Prostate hits 100th TULSA Procedure; volumes up 500% under new Medicare model","bullets":["Texas Prostate, led by Dr. James Cochran, performed its 100th TULSA Procedure at Dallas Medical Center.","Procedure volumes increased 500% after transitioning from private pay to a Medicare model via Dallas Medical Center.","Dr. Cochran cited TULSA's MRI-guidance and thermography for broader treatment range and improved safety versus HIFU.","CEO Arun Menawat said the model demonstrates a path for accelerating TULSA adoption across prostate care."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-001971","json":"https://secwatch.observer/filing/0001171843-26-001971.json","markdown":"https://secwatch.observer/filing/0001171843-26-001971.md","text":"https://secwatch.observer/filing/0001171843-26-001971.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326001971/0001171843-26-001971-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326001971/f8k_032726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:38:33.112912+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}